NCT00326716 Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women Status COMPLETED Phase PHASE1
NCT00326586 A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer Status COMPLETED Phase PHASE1
NCT00326131 A Phase I Study of a Single Dose of Radio-labeled BMS-275183 in Patients With Advanced Cancer Status TERMINATED Phase PHASE1
NCT00324155 Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma Status COMPLETED Phase PHASE3
NCT00324077 Phase I Study of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase Status WITHDRAWN Phase PHASE1
NCT00323882 Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00320255 A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer Status COMPLETED Phase PHASE2
NCT00320190 Study of Dasatinib in Patients With Chronic Phase Chronic Myeloid Leukemia and a Suboptimal Response to Imatinib Status TERMINATED Phase PHASE2
NCT00319735 Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas Status COMPLETED Phase PHASE2
NCT00315237 Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Cell Carcinoma (TCC) of the Urothelial Tract Status COMPLETED Phase PHASE3
NCT00312754 A Phase IV Study of BMS-232632 in HIV+ Patients With Metabolic Syndrome Status TERMINATED Phase PHASE4
NCT00312598 Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine Status COMPLETED Phase N/A
NCT00309023 Study of BMS-663513 in Patients With Advanced Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00308074 An Open-Label Trial of Aripiprazole in Autism Spectrum Disorders Status COMPLETED Phase PHASE2
NCT00306878 Phase I Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris Status COMPLETED Phase PHASE1
NCT00306202 Study of Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia Status COMPLETED Phase PHASE1
NCT00305201 Cardiovascular Risk Markers and Response to Statins After Kawasaki Disease Status WITHDRAWN Phase PHASE2
NCT00300027 Study of BMS-582664 in Combination With Either FOLFIRI or FOLFOX for Gastrointestinal (GI) Malignancies Status TERMINATED Phase PHASE1